Evogene Ltd. (EVGN) Form 6-K — Jul 31, 2026
Evogene has filed a proxy statement for its 2026 Annual General Meeting, announcing a contested board election between the incumbent seven-member 'Evogene Slate' and the four-member 'Pure Capital Slate' nominated by activist shareholders L.I.A. Pure Capital Ltd. and Invest-Pro Shukai Hon Ltd. The dissident group, holding 14.67% of the company, demanded the meeting to remove current board members and install their own nominees, while the current board advocates for its strategic transformation including operational restructuring and workforce reduction.
Key figures
- Shares Outstanding
- 15733507
- Workforce reduction
- ~67%
- Nasdaq minimum bid price
- $1.00
- Share price july 27 2026
- $0.52
- Authorized share increase
- 120000000
- Reverse split ratio range
- 1-for-2 to 1-for-15
- Expected annual cash burn 2026
- $8.5-9.5 million
- Pure capital ownership percent
- 14.67%
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.